Overview of the 3rd isirv-Antiviral Group Conference - advances in clinical management

    Thumbnail
    Download
    Citations
    Scopus
    Altmetric
    12
    Author
    Hurt, AC; Hui, DS; Hay, A; Hayden, FG
    Date
    2015-01-01
    Source Title
    Influenza and Other Respiratory Viruses
    Publisher
    WILEY
    University of Melbourne Author/s
    Hurt, Aeron
    Affiliation
    Melbourne School of Population and Global Health
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Hurt, A. C., Hui, D. S., Hay, A. & Hayden, F. G. (2015). Overview of the 3rd isirv-Antiviral Group Conference - advances in clinical management. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 9 (1), pp.20-31. https://doi.org/10.1111/irv.12293.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/259104
    DOI
    10.1111/irv.12293
    Abstract
    This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.

    Export Reference in RIS Format     

    Collections